1 enrolling by invitation. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Enrolling by invitation 1 |
Follow Osteoporosis: new trials by email Literature Review of Osteoporosis trials Research Report on Osteoporosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Compare the Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of SAL023 and Italy-Manufactured Evenity in Healthy Subjects SAL0123, Romosozumab - Osteoporosis | Phase 1 | Enrolling by invitation | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 118 | 2025-10-19 | 2026-02-03 |
Bone Diseases (1) · Bone Diseases, Metabolic (1) · Metabolic Diseases (1) · Musculoskeletal Diseases (1) · Nutritional and Metabolic Diseases (1)
romosozumab (1)
Shenzhen Salubris Pharmaceuticals Co., Ltd. (1)
China (1)